Surgical sealants and adhesives market seen reaching $4.99 billion by 2030

The surgical sealants and adhesives market is projected to grow from $2.96 billion in 2025 to $4.99 billion by 2030, driven by more procedures, minimally invasive surgery and demand for sutureless closure. North America led the market in 2025, while cosmetic surgery trends are adding momentum.

Why it matters: - Surgical sealants and adhesives are becoming more important in operating rooms as hospitals look for ways to reduce blood loss, limit complications and speed recovery. - The market’s expected rise to $4.99 billion by 2030 signals sustained demand for alternatives to staples and sutures. - Growth in cosmetic surgery is adding another use case, especially where precise tissue bonding and reduced scarring matter.

What happened: - The Business Research Company said the global surgical sealants and adhesives market will expand from $2.96 billion in 2025 to $3.29 billion in 2026. - The report projects the market will reach $4.99 billion by 2030, based on an 11.0% compound annual growth rate. - North America led the market in 2025, with Western Europe ranking second. - The report also covers Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East and Africa.

The details: - The market’s near-term growth is tied to more surgical procedures, greater focus on reducing complications and wider use of advanced wound closure technologies. - Better hospital surgical capacity and improved access to biological materials are also supporting demand. - The report cites rising preference for minimally invasive surgeries, faster recovery times, broader use in regenerative medicine and more investment in innovative biomaterials. - A shift toward non-suture closure techniques is another key growth driver. - Emerging trends include more bio-based sealants, stronger demand for sutureless wound closure products, wider use of absorbable adhesives, growth in hemostatic sealants and better tissue-compatible formulations. - Surgical sealants and adhesives are designed to repair damaged tissue and prevent leakage of fluids or air during or after surgery. - These products can reduce blood loss and reinforce wound sites while allowing natural tissue movement.

Between the lines: - The market forecast suggests surgery is moving toward faster, less invasive procedures that rely more on specialized materials and less on traditional closures. - Cosmetic surgery is not the only driver, but it provides a visible demand signal for products that improve precision and recovery. - The report’s emphasis on biomaterials and tissue compatibility points to a broader shift toward products that work with the body rather than just sealing a wound. - In the UK, cosmetic surgery data from the British Association of Aesthetic Plastic Surgeons showed women accounted for 93.5% of cosmetic surgeries in 2024, with 25,663 procedures performed, up 6% from the prior year. - Eyelid surgery rose 15%, and breast augmentation remained the most common cosmetic procedure at 5,202 cases, up 6%.

What's next: - The market is expected to keep growing at an 11.0% pace through 2030. - Demand should continue to build around minimally invasive procedures, regenerative medicine and sutureless closure products. - More use of absorbable and bio-based sealants could reshape product development over the next several years. - The Business Research Company also offered a free sample report and a full market report for readers seeking deeper data. - More information is available in the full report and the free sample.

The bottom line: - Surgical sealants and adhesives are moving from niche surgical aids to core tools in modern wound closure, and the market outlook remains firmly upward.